Latest News

What Modern Business Plans Need In 2026 A modern business plan in 2026 is very different from the static documents investors saw a decade ago. Today, plans need to function as working operating guides, not just fundraising brochures. That means sharper financials, clearer execution paths, and stronger evidence that the founders understand their market, their [...]

Vanguard's ultra-low costs clash with State Street's superior recent returns. Sector tilts and volatility profiles diverge sharply between these two small-cap rivals.

Verizon is adding new subscribers at a strong clip, but Space Exploration Technologies is an overhang.

Record copper prices drove adjusted EBITDA to CAD 2.3 billion, up 97% year over year.

WEC raises guidance and unveils $47.5B five-year plan to power data center demand surge.

AUM surged 21% to $346 billion as capital formation accelerated across platforms.

Choice Properties REIT (TSX:CHP.UN) shares stand out as a compelling high-yield pick-up after an 11% drop.

Operating expenses are declining even as the company pivots to higher-value projects, testing whether cost discipline can sustain growth amid search headwinds.

Revenue surged 36.7% but profitability guidance fell as medical costs climbed.

Testing volumes surged 51% as NavDx integration drove revenue and margin gains.

Net income jumped 25% despite lower sales, backed by strong margins and $13.5B backlog.

Net sales grew 2% to $962.6 million as international strength offset U.S. wholesale delays.

Fuel headwinds offset revenue gains as net income rose 3% to $120 million.

Server CPU demand hit 15-year highs as AI infrastructure spending surged.

Niccol outlines tech modernization and store renovations for fiscal 2027 growth.

IKC outperformance helped offset tech investment drag in Q3.

Record $1.2B revenue driven by AI data center and communications strength.

Base business sales surged 16%, marking strongest growth in over a decade.

Net income surged 15.4% while deposit balances grew 14% year over year.

Revenue surged to $353.2 million as Attruby gains traction in rare disease markets.

AI tools cut submission time to 3 minutes as pricing pressures persist.

Record patient starts and type 2 diabetes share gains fuel 11% revenue growth.

Dravet syndrome trial enrollment exceeded targets with zero discontinuations.

VanEck's concentrated 26-stock portfolio delivered stronger five-year returns and lower volatility, while State Street's 62-holding fund offers broader diversification and lower fees.

A land bank spanning seven cities and proprietary fiber networks create structural barriers that insulate long-term returns from new competition.